
Humana Inc. (HUM)
$
184.1
+5.27 (2.86%)
Key metrics
Financial statements
Free cash flow per share
12.8554
Market cap
22.1 Billion
Price to sales ratio
0.1708
Debt to equity
0.7005
Current ratio
2.0025
Income quality
1.5816
Average inventory
0
ROE
0.0659
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Humana Inc., along with its subsidiaries, is a prominent health and well-being company operating in the United States through three distinct segments: Retail, Group and Specialty, and Healthcare Services. The company reported depreciation and amortization expenses of $824,000,000.00 reflecting the wear and tear of its assets. Additionally, the net total of other income and expenses is $0.00 highlighting its engagement in non-core financial activities. The company reported an income before tax of $1,453,000,000.00 showcasing its pre-tax profitability, while incurring an interest expense of $631,000,000.00 reflecting its debt servicing obligations. The cost of revenue for the company is $110,812,000,000.00 illustrating its production and operational expenses. Humana offers a range of medical and supplemental benefit plans tailored for individuals and maintains contracts with the Centers for Medicare and Medicaid Services to manage the Limited Income Newly Eligible Transition prescription drug plan program. Furthermore, it collaborates with various states to deliver Medicaid, dual eligible, and long-term support services benefits, as well as providing commercial fully insured medical and specialty health insurance benefits that include dental, vision, and other supplemental options. The company also administers services solely for its employer groups and individual clients, alongside military services like the TRICARE T2017 East Region contract. With a substantial membership base, as of December 31, 2021, the company had around 17 million members in medical benefit plans and approximately 5 million in specialty products. In terms of market performance, the stock is priced at $252.66 positioning it in the higher-end market. It shows a high average trading volume of 1,910,035.00 indicating strong liquidity, while maintaining a mid-range market capitalization of $22,142,271,819.00 categorizing the company as a steady performer. As a key player in the Medical - Healthcare Plans industry, Humana contributes significantly to the overall market landscape and belongs to the Healthcare sector, driving innovation and growth. Through its expansive offerings and substantial member base, Humana Inc. continues to impact the health and well-being of millions while leveraging its financial performance and market position to sustain its growth objectives.
Investing in Humana Inc. (HUM) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Humana Inc. stock to fluctuate between $169.61 (low) and $315.35 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-02-13, Humana Inc.'s market cap is $22,142,271,819, based on 120,273,068 outstanding shares.
Compared to Eli Lilly & Co., Humana Inc. has a Lower Market-Cap, indicating a difference in performance.
Humana Inc. pays dividends. The current dividend yield is 1.37%, with a payout of $0.89 per share.
To buy Humana Inc. (HUM) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for HUM. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Humana Inc.'s last stock split was 3:2 on 1991-08-01.
Revenue: $129,664,000,000 | EPS: $9.87 | Growth: -1.40%.
Visit https://www.humana.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $571.30 (2022-11-03) | All-time low: $169.61 (2026-02-11).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

zacks.com
HUM incurs a wider year-over-year loss in Q4 due to rising costs, weaker investment income and membership declines. Yet, revenues climb 12% on CenterWell strength.

seekingalpha.com
Humana Inc. (HUM) Q4 2025 Earnings Call Transcript

wsj.com
Humana reported a wider fourth-quarter loss as medical costs continue to rise, dragging down margins for the company's core Medicare Advantage business.

reuters.com
Humana forecast annual profit below Wall Street estimates on Wednesday, as the health insurer expects a hit from lower quality ratings for its Medicare Advantage plans for older adults.

businesswire.com
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net (loss) earnings per share (EPS) for the quarter ended December 31, 2025 (4Q25) versus the quarter ended December 31 31, 2024 (4Q24) and for the year ended December 31, 2025 (FY 2025) versus the year ended December 31, 2024 (FY 2024) as noted in the tables below. Consolidated (loss) income before income taxes and equity in net losses (pretax results) in millions 4Q25 (a) 4Q24 (a) FY 2025.

zacks.com
HUM heads into Q4 with declining medical membership and rising costs, clouding earnings despite expectations for solid revenue growth.

pymnts.com
Health insurance company Humana launched Agent Assist, a new artificial intelligence-driven support tool developed with Google Cloud, according to a Tuesday (Feb. 3) press release. The tool is designed to help member advocates deliver faster, more personalized responses to health benefits and eligibility questions, the release said.

prnewswire.com
Humana introduces Agent Assist to help member advocates deliver faster, more personalized support, enabled by an expanded partnership with Google Cloud LOUISVILLE, Ky. and SUNNYVALE, Calif.

barrons.com
The Trump administration proposed keeping Medicare rates roughly flat this year.

prnewswire.com
SAN DIEGO, Jan. 21, 2026 /PRNewswire/ --The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in Humana Inc shares. Investors who purchased shares of Humana Inc. (NYSE: HUM) prior to July 2022 and continue to hold any of those NYSE: HUM shares have also certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
See all news